Institutional members access full text with Ovid®

Share this article on:

Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease

SHIROMA, ERIC J.; COOK, NANCY R.; MANSON, JOANN E.; MOORTHY, MV; BURING, JULIE E.; RIMM, ERIC B.; LEE, I-MIN

Medicine & Science in Sports & Exercise: January 2017 - Volume 49 - Issue 1 - p 40–46
doi: 10.1249/MSS.0000000000001063
Epidemiology

Purpose: This study aimed to examine the association of strength training with incident type 2 diabetes and cardiovascular disease risk.

Methods: We followed 35,754 healthy women (mean age = 62.6 yr, range = 47.0–97.8) from the Women’s Health Study, who responded to a health questionnaire that included physical activity questions in 2000, assessing health outcomes through annual health questionnaire through 2014 (mean ± SD follow-up = 10.7 ± 3.7 yr). Incident type 2 diabetes (N cases = 2120) and cardiovascular disease (N cases = 1742) were confirmed on medical record review. Cases of cardiovascular disease were defined as confirmed cases of myocardial infarction, stroke, coronary artery bypass graft, angioplasty, or cardiovascular disease death.

Results: Compared with women who reported no strength training, women engaging in any strength training experienced a reduced rate of type 2 diabetes of 30% (hazard ratio = 0.70, 95% confidence interval = 0.61–0.80) when controlling for time spent in other activities and other confounders. A risk reduction of 17% was observed for cardiovascular disease among women engaging in strength training (hazard ratio = 0.83, 95% confidence interval = 0.72, 0.96). Participation in both strength training and aerobic activity was associated with additional risk reductions for both type 2 diabetes and cardiovascular disease compared with participation in aerobic activity only.

Conclusions: These data support the inclusion of muscle-strengthening exercises in physical activity regimens for reduced risk of type 2 diabetes and cardiovascular disease, independent of aerobic exercise. Further research is needed to determine the optimum dose and intensity of muscle-strengthening exercises.

1Laboratory of Epidemiology and Population Science, Intramural Research Program of the National Institutes of Health, National Institute on Aging, Bethesda, MD; 2Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; 3Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; and 4Department of Nutrition, Harvard School of Public Health, Boston, MA

Address for correspondence: Eric J Shiroma, Sc.D., M.Ed., 7201 Wisconsin Ave., Gateway Bldg., Suite 3C309, Bethesda, MD 20814; E-mail: Eric.shiroma@nih.gov.

Submitted for publication February 2016.

Accepted for publication July 2016.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.acsm-msse.org).

© 2017 American College of Sports Medicine